Genetic Technologies
GENE
#10613
Rank
โ‚น0.35 B
Marketcap
โ‚น72.58
Share price
0.00%
Change (1 day)
-64.81%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.16 a decrease over its 2022 EPS that were of -โ‚น2.09.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.1650.65%
2022-โ‚น2.09-99.04%
2021-โ‚น217.59-46.67%
2020-โ‚น407.98-99.38%
2019-โ‚น65,27710809.09%
2018-โ‚น598.38-41.07%
2017-โ‚น1,015-18.37%
2016-โ‚น1,244-40.24%
2015-โ‚น2,082-53.41%
2014-โ‚น4,468-10.66%
2013-โ‚น5,00171.3%
2012-โ‚น2,919-622.73%
2011โ‚น558.48-108.8%
2010-โ‚น6,346-3.92%
2009-โ‚น6,60673.47%
2008-โ‚น3,80824.96%
2007-โ‚น3,047-10.93%
2006-โ‚น3,421-48.62%
2005-โ‚น6,659-8.31%
2004-โ‚น7,262
2003N/A-100%
2002-โ‚น4,509-9.36%
2001-โ‚น4,975

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,686N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น841.59N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น481.04N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น999.09N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.46N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น263.49N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น410.83N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,278N/A๐Ÿ‡บ๐Ÿ‡ธ USA